gvtcx

DHSC:SCI: support for a review of voluntary scheme for branded medicines

Department of Health and Social Care Published 22 May 2025 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£99,600
Statuscomplete
Category (CPV) 72224000
Deadline13 Apr 2025
Contract start14 Apr 2025
Contract end15 Jul 2025
Procedureselective
SME suitableNo
OCIDocds-b5fd17-33ccd609-e5d8-4930-81d5-168f38896858

Award

SupplierValueDateStatus
PA CONSULTING SERVICES LIMITED £99,600 15 Apr 2025 active

description

  • The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) is a rebate scheme on the pharmaceutical industry which generates income for the NHS and controls the bottom line of the NHS budget. This is critical to the financial sustainability of the NHS by controlling how much the NHS spends on branded drugs - this is one of the largest commercial agreements in Government. VPAG also includes important elements that support the wider medicines environment, including supporting greater and timelier patient access to new clinically and cost-effective medicines, and support for innovation.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
22 May 2025 Award (award) · 4b3c126f-7352-4034-889d-0555f78aaa25-846421

more from Department of Health and Social Care

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.